J&J May Buy Ollin Biosciences for Up to $3.4 Billion, FT Reports
Johnson & Johnson could announce a deal as soon as Monday, the Financial Times reported, citing people familiar with the matter.
Johnson & Johnson NYSE:JNJ could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with the matter.Here are some details